Parinaz Ehtezazi Alamdari

Contributing to the pharmaceutical field for neurological diseases has always been one of the priorities in research areas, particularly with the ageing population of the world resulting in an increase in Alzheimer's disease and emerging pathogens such as Covid-19. With the impenetrable Blood Brain Barrier, the brain is too inaccessible to therapeutics, leading us to apply new technologies such as immunosafe nanoparticles to cross BBB.

I am interested in this area of pharmacy, targeting brain tissue, releasing efficient cargo molecules, and reducing inflammation which are all essential for neural cell salvage.

Degrees

Tehran University of Medical Sciences, Iran, Medical Doctorate